|
Hot Stocks
|
Flotek Industries… Flotek Industries announced that Director Harsha V. Agadi will become interim Chief Executive Officer of Flotek, effective immediately. He succeeds John W. Gibson, Jr., who has transitioned out of the role of Chairman, President, and Chief Executive Officer to pursue other professional opportunities. In addition, Chief Operating Officer Ryan Ezell has been promoted to President and Independent Lead Director David Nierenberg has been appointed Chairman of the Board. The Board of Directors has commenced a search for the company's next Chief Executive Officer. Agadi said, "Since I joined the Flotek Board in 2020, I have witnessed the Company's growth that has brought us to this pivotal moment. I am excited to take on this role as we work to identify our next leader and look forward to working alongside David, Ryan, and our deeply talented Flotek colleagues to ensure a seamless transition to our next CEO. Flotek's potential is unlimited in this sector, and we are well-positioned to gain market share over the coming years." ShowHide Related Items >><< - 12/19/22
- Flotek appoints Bond Clement CFO
- 08/10/22
- Flotek enters agreement to provide 20 JP3 Verax analyzer units to ProFrac
- 07/20/22
- Flotek expects Q2 revenue in excess of $28M, one est. $22.8M
- 07/20/22
- Fly Intel: Pre-market Movers
|
|
On The Fly
|
Check out this morning's… ShowHide Related Items >><< - 06/23/22
- Wynn Resorts Macau announces concession extension agreement
- 07/20/22
- VBL Therapeutics sinks 80% to 42c after Phase 3 ovarian cancer miss
- 07/20/22
- VBL Therapeutics Phase 3 ovarian cancer trial misses primary endpoints
- 07/19/22
- Vascular Biogenics trading resumes
- 07/19/22
- Vascular Biogenics trading halted, news pending
- $201.70 /
+10.72 (+5.61%) - 07/19/22
- Netflix plans to spend roughly $17B on content over next few years
- 07/19/22
- Netflix plans wider rollout for paid sharing next year
- 07/19/22
- Netflix says negotiating for rights to put ads in other shows
- 07/19/22
- Netflix says business remains 'resilient'
- 07/20/22
- Nasdaq announces 3-for-1 stock split
- 07/20/22
- Nasdaq sees 2022 non-GAAP tax rate 24%-26%
- 06/29/22
- Nasdaq announces it welcomed 108 IPOs in first half of 2022
- 06/02/22
- Nasdaq enters agreement to acquire Metrio
- 07/15/22
- New Jersey reports June gaming revenue up 2.2% to $401.5M
- 07/04/22
- Fly Intel: Top five weekend stock stories
- 07/01/22
- Macau reports June casino revenue down 62.1% to 2.48B patacas
- 06/30/22
- Nevada reports May statewide gaming win up 5.71% to $1.3B
- 05/10/22
- Flotek's sharholders approve agreement with ProFrac Holdings
- 04/04/22
- Flotek regains compliance with NYSE continued listing standard
- 02/17/22
- Flotek nearly doubles on reopening after announcing $1B-plus contract award
- 02/17/22
- Flotek trading resumes
- 07/19/22
- Forestar Group sees FY22 pre-tax margin roughly 14.25%
- 01/27/22
- Forestar sees 19.5K-20K lot deliveries in FY22
- 07/15/22
- Baker Hughes reports U.S. rig count up 4 to 756 rigs
- 07/15/22
- Baker Hughes reports U.S. rig count up 4 to 756 rigs
- 07/08/22
- Baker Hughes reports U.S. rig count up 2 to 752 rigs
- 07/08/22
- Baker Hughes reports U.S. rig count up 2 to 752 rigs
- 05/19/22
- Bath & Body Works sees FY inflation impact $225M-$250M
- 05/19/22
- Bath & Body Works to test new personal care line, including face and hair care
- 05/19/22
- Bath & Body Works: Overall Q1 transactions up low single digits vs. last year
- 05/16/22
- Lone Pine adds TSMC in Q1, exits KE Holdings and Adobe
- $498.60 /
+25.11 (+5.30%) - 04/29/22
- ASML selects PwC as preferred audit firm, to become external auditor in 2025
- 07/20/22
- Abbott reports Q2 Worldwide Medical Devices sales up 2.5% on reported basis
- 07/20/22
- Abbott: FY22 guidance includes projected COVID-19 testing-related sales of $6.1B
- 07/20/22
- Abbott reports Q2 Worldwide Diagnostics sales up 33.1% on a reported basis
- 07/19/22
- FDA evaluating agency's programs and oversight after Juul, baby formula issues
- 07/19/22 Deutsche Bank
- Las Vegas Sands price target lowered to $50 from $53 at Deutsche Bank
- 07/06/22 JPMorgan
- JPMorgan likes Las Vegas Sands risk/reward, sees 20% share upside
- 07/05/22 Citi
- Las Vegas Sands price target lowered to $56 from $57 at Citi
- 06/29/22 Barclays
- Barclays initiates gaming sector, says Caesars best positioned
- 07/05/22 Citi
- Wynn Resorts price target lowered to $87.50 from $92 at Citi
- 06/28/22 Barclays
- Wynn Resorts initiated with an Equal Weight at Barclays
- 05/11/22 Deutsche Bank
- Wynn Resorts price target lowered to $92 from $123 at Deutsche Bank
- $201.70 /
+10.72 (+5.61%) - 07/20/22 Oppenheimer
- Netflix subscriber beat unlikely to alleviate concerns, says Oppenheimer
- 07/20/22 Evercore ISI
- Evercore says market will need to see progress from Netflix for premium multiple
- 07/20/22 Morgan Stanley
- Netflix price target raised to $230 from $220 at Morgan Stanley
- 07/20/22 Wedbush
- Wedbush remains bullish on Netflix following quarterly results
- 07/18/22 BTIG
- Abbott price target lowered to $126 from $130 at BTIG
- 07/18/22 Stifel
- Abbott price target lowered to $126 from $136 at Stifel
- 07/13/22 TD Cowen
- Abbott price target lowered to $130 from $150 at Cowen
- 07/06/22 Wolfe Research
- Wolfe starts Abbott at Underperform, says stock price 'doesn't make sense'
- 07/15/22 UBS
- Bath & Body Works price target lowered to $42 from $70 at UBS
- 07/13/22 Evercore ISI
- Evercore downgrades Bath & Body Works on reversion in consumer spending
- 07/13/22 Evercore ISI
- Bath & Body Works downgraded to In Line from Outperform at Evercore ISI
- 07/12/22 Raymond James
- Bath & Body Works initiated with a Strong Buy at Raymond James
- $498.60 /
+25.11 (+5.30%) - 07/15/22 Wells Fargo
- ASML price target lowered to $600 from $750 at Wells Fargo
- 06/30/22 Piper Sandler
- Piper says memory contract pricing declines negative for Micron, semi equipment
- 06/29/22 Argus
- ASML initiated with a Buy at Argus
- 05/26/22 Piper Sandler
- ASML price target lowered to EUR 630 from EUR 767 at Piper Sandler
- 07/20/22 BTIG
- Forestar Group cut to Neutral at BTIG after 'weak' Q2, uncertainty on FY23
- 07/20/22 BTIG
- Forestar Group downgraded to Neutral from Buy at BTIG
- 04/28/22 Citi
- Forestar Group price target lowered to $25 from $30 at Citi
- 07/20/22 H.C. Wainwright
- VBL Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
- 07/20/22 Oppenheimer
- VBL Therapeutics downgraded to Perform from Outperform at Oppenheimer
- 07/18/22 Oppenheimer
- VBL Therapeutics assumed with an Outperform at Oppenheimer
- 04/28/22 Chardan
- VBL Therapeutics initiated with a Buy at Chardan
- 07/13/22 Morgan Stanley
- Baker Hughes price target lowered to $35 from $40 at Morgan Stanley
- 07/13/22 Barclays
- Baker Hughes price target lowered to $46 from $47 at Barclays
- 06/08/22 Barclays
- Baker Hughes price target raised to $47 from $40 at Barclays
- 04/27/22 Barclays
- Baker Hughes price target raised to $40 from $31 at Barclays
- 07/13/22 Deutsche Bank
- Nasdaq price target lowered to $175 from $184 at Deutsche Bank
- 06/27/22 Jefferies
- Nasdaq price target lowered to $174 from $182 at Jefferies
- 05/19/22 Deutsche Bank
- Nasdaq price target lowered to $184 from $207 at Deutsche Bank
- 04/21/22 Deutsche Bank
- Nasdaq price target lowered to $207 from $210 at Deutsche Bank
- 05/10/22
- Wynn Resorts reports Q1 adjusted EPS ($1.21), consensus ($1.15)
- 05/10/22
- Notable companies reporting after market close
- 02/15/22
- Wynn Resorts reports Q4 EPS ($1.54), consensus ($1.25)
- 02/15/22
- Notable companies reporting after market close
- 05/17/22
- VBL Therapeutics reports Q1 EPS (13c), consensus (11c)
- 03/23/22
- VBL Therapeutics reports FY21 EPS (45c), consensus (41c)
- $201.70 /
+10.72 (+5.61%) - 07/19/22
- Netflix sees Q3 EPS $2.14, consensus $2.77
- 07/19/22
- Netflix reports Q2 EPS $3.20, consensus $2.96
- 07/19/22
- Notable companies reporting after market close
- 04/19/22
- Netflix sees Q2 EPS $3.00, consensus $3.01
- 07/20/22
- Nasdaq reports Q2 adjusted EPS $2.07, consensus $1.93
- 04/20/22
- Nasdaq reports Q1 adjusted EPS $1.97, consensus $1.95
- 01/26/22
- Nasdaq reports Q4 adjusted EPS $1.93, consensus $1.77
- 04/27/22
- Las Vegas Sands reports Q1 consolidated adjusted property EBITDA $110M
- 04/27/22
- Las Vegas Sands reports Q1 adjusted EPS (40c), consensus (24c)
- 04/27/22
- Notable companies reporting after market close
- 01/26/22
- Las Vegas Sands reports Q4 adjusted EPS (22c), consensus (25c)
- 07/20/22
- Flotek expects Q2 revenue in excess of $28M, one est. $22.8M
- 07/19/22
- Forestar Group reports Q3 EPS 80c, consensus 81c
- 04/21/22
- Forestar backs FY22 revenue view $1.7B, consensus $1.69B
- 04/21/22
- Forestar reports Q2 EPS 96c, consensus 70c
- 01/27/22
- Forestar reports Q1 EPS 81c, consensus 67c
- 07/20/22
- Baker Hughes reports Q2 EPS 11c, consensus 22c
- 04/20/22
- Baker Hughes reports Q1 EPS 15c, consensus 19c
- 04/20/22
- Baker Hughes reports Q1 adjusted EPS 15c, consensus 19c
- 04/19/22
- Notable companies reporting before tomorrow's open
- 07/20/22
- Bath & Body Works lowers 2022 sales view to down mid to high single digits
- 07/20/22
- Bath & Body Works lowers Q2 EPS view 40c-42c from 60c-65c, consensus 62c
- 05/19/22
- Bath & Body Works sees FY sales up low single digits, consensus $7.72B
- 05/19/22
- Bath & Body Works sees Q2 sales up low single digits, consensus $1.65B
- $498.60 /
+25.11 (+5.30%) - 07/20/22
- ASML sees FY revenue growth around 10%
- 07/20/22
- ASML sees Q3 revenue EUR 5.1B-EUR 5.4B, gross margin 49%-50%
- 07/20/22
- ASML reports Q2 EPS EUR 3.54 vs. EUR 1.73 last quarter
- 04/20/22
- ASML sees Q2 revenue EUR 5.1B - EUR 5.3B
- 07/20/22
- Abbott raises FY22 adjusted EPS view to at least $4.90 from at least $4.70
- 07/20/22
- Abbott reports Q2 adjusted EPS $1.43, consensus $1.12
- 07/19/22
- Notable companies reporting before tomorrow's open
- 06/23/22
- Fanatics in discussions to enter sports betting business, CNBC reports
- $201.70 /
+10.72 (+5.61%) - 07/19/22
- Netflix acquires Australian animation studio Animal Logic, Deadline reports
- 07/12/22
- Netflix in talks to amend studio deals for ad platform, WSJ reports
- 07/12/22
- Netflix in talks to amend programming deals for ads, WSJ reports
- 07/11/22
- Netflix looks at Comcast exec to potentially oversee ad-supported tier, WSJ says
- 07/05/22
- Nasdaq, NYSE victorious in market data court dispute with SEC, WSJ reports
- 06/24/22
- SoftBank's Masayoshi Son prefers U.S. share listing for Arm, FT reports
- 02/28/22
- Nasdaq, NYSE pause trading in stocks of Russia-based companies, Reuters says
- 07/20/22
- Macau plans to reopen casinos on July 23, Bloomberg reports
- 07/11/22
- Macau shuts casinos, other businesses amid Covid-19 outbreak, WSJ reports
- 07/05/22
- Indictment of Alvin Chau reveals vast criminal conspiracy, NIkkei reports
- 07/02/22
- Las Vegas Sands could win big as China eases COVID rules, Barron's says
- 04/21/22
- Some U.S. oilfield firms join push for Venezuela resumption, Reuters says
- $498.60 /
+25.11 (+5.30%) - 07/05/22
- U.S. wants ASML to stop selling chipmaking gear to China, Bloomberg says
- 07/05/22
- U.S. seeks to ban ASML ultraviolet system sales to China, Bloomberg says
- 07/05/22
- U.S. pushing Netherlands to ban ASML chips to China, Bloomberg says
- 06/16/22
- TSMC says it will have new version of ASML chipmaking tool in 2024, Reuters says
- 07/10/22
- Abbott reopens Michigan baby formula plant, Reuters reports
- 06/16/22
- Abbott halts production at baby formula plant following storms, WSJ reports
- 06/09/22
- Abbott received employee complaint on plant earlier than known, WSJ reports
- 06/06/22
- Abbott resumes production in Michigan, formula shortage to continue, WSJ report
- $201.70 /
+10.72 (+5.61%) - 07/19/22
- Fly Intel: After-Hours Movers
- 07/19/22
- What Wall Street is saying about Netflix ahead of earnings
- 07/13/22
- What You Missed On Wall Street On Wednesday
- 07/12/22
- What You Missed On Wall Street On Tuesday
- 02/28/22
- What You Missed On Wall Street On Monday
- 02/15/22
- What You Missed On Wall Street On Tuesday
- 02/15/22
- What You Missed On Wall Street This Morning
- 02/15/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 07/15/22
- Bet On It: Various states seeing betting die down for summer
- 07/11/22
- What You Missed On Wall Street On Monday
- 07/11/22
- What You Missed On Wall Street This Morning
- 07/11/22
- Fly Intel: Pre-market Movers
- 04/21/22
- Fly Intel: After-Hours Movers
- 07/05/22
- What You Missed On Wall Street This Morning
- 04/26/22
- What You Missed On Wall Street On Tuesday
- 04/26/22
- What You Missed On Wall Street This Morning
- 04/20/22
- What You Missed On Wall Street On Wednesday
- 06/30/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 06/29/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 05/19/22
- What You Missed On Wall Street On Thursday
- 05/19/22
- What You Missed On Wall Street This Morning
- $498.60 /
+25.11 (+5.30%) - 07/05/22
- What You Missed On Wall Street On Tuesday
- 06/30/22
- Here's what Wall Street is saying about Micron ahead of earnings
- 07/06/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 06/16/22
- What You Missed On Wall Street This Morning
- 06/16/22
- Fly Intel: Pre-market Movers
- 06/24/22
- Early notable gainers among liquid option names on June 24th
- 06/15/22
- Unusually active option classes on open June 15th
- 06/08/22
- Early notable gainers among liquid option names on June 8th
- 06/16/22
- Largest borrow rate increases among liquid names
- $201.70 /
+10.72 (+5.61%) - 07/19/22
- Netflix options imply 12.7% move in share price post-earnings
- 06/22/22
- Netflix call volume above normal and directionally bullish
- 06/22/22
- Early notable gainers among liquid option names on June 22nd
- 04/22/22
- Notable open interest changes for April 22nd
- 07/14/22
- Early notable gainers among liquid option names on July 14th
- 06/28/22
- Early notable gainers among liquid option names on June 28th
- 06/06/22
- Early notable gainers among liquid option names on June 6th
- 05/16/22
- Las Vegas Sands call buyer realizes 33% same-day gains
- 03/30/22
- Flotek options imply 13.2% move in share price post-earnings
- 03/28/22
- Flotek options imply 12.3% move in share price post-earnings
- 03/21/22
- Flotek options imply 15.7% move in share price post-earnings
- 03/17/22
- Flotek options imply 15.2% move in share price post-earnings
- 03/21/22
- Baker Hughes put volume heavy and directionally bearish
- 03/07/22
- Early notable gainers among liquid option names on March 7th
- 02/11/22
- Early notable gainers among liquid option names on February 11th
- 01/20/22
- Early notable gainers among liquid option names on January 20th
- 07/06/22
- Bath & Body Works put volume heavy and directionally bearish
- 06/21/22
- Bath & Body Works put volume heavy and directionally bearish
- 06/09/22
- Bath & Body Works call volume above normal and directionally bullish
- 05/18/22
- Bath & Body Works options imply 10.5% move in share price post-earnings
- $498.60 /
+25.11 (+5.30%) - 05/09/22
- Largest borrow rate increases among liquid names
- 04/26/22
- ASML put volume heavy and directionally bearish
- 06/22/22
- Abbott put volume heavy and directionally bearish
- 02/18/22
- Abbott put volume heavy and directionally bearish
- 01/31/22
- Unusually active option classes on open January 31st
- 01/26/22
- Unusually active option classes on open January 26th
|
|
Earnings
|
Flotek Industries… Flotek Industries announced that it expects second quarter 2022 revenue to be in excess of $28M compared to first quarter 2022 revenue of $12.9M and second quarter 2021 revenue of $9.2M. "The revenue growth we expect to achieve in the second quarter is strong evidence that we are successfully ramping up the transformational ProFrac contract, and I am very proud of our team. During the second quarter, we serviced an average of 8 ProFrac hydraulic fracturing fleets with no service quality issues, and expect to service an average of 16 or greater fleets in the third quarter. Since the April 1, 2022 effective date of the contract, we have delivered over 31 million pounds of chemistry to ProFrac. Combined with the 9 million pounds of chemistry delivered to our transactional customers, total delivered volume in the second quarter was approximately double what we delivered for the entire year in 2021. We are delighted with how far we have come over a short period of time, and are very excited about the future. While we still have additional work to do in order to achieve the full scope of the contract, we are up to the task," said CEO John W. Gibson, Jr. While delivered volume and revenue are expected to show strong growth over the first quarter 2022, the ramp up required the company to incur some one-time expenses, including costs related to the mobilization of additional field deployment tanks, which increased from 20 to 101. In addition, freight and logistics costs are expected to be significantly above expectations, consistent with inflation being experienced by peers. However, these issues are not expected to interrupt consistent improvement in Adjusted EBITDA margin through the second half of 2022, and the company still expects to generate positive Adjusted EBITDA excluding convertible notes amortization before the end of the fourth quarter 2022. ShowHide Related Items >><< - 05/10/22
- Flotek's sharholders approve agreement with ProFrac Holdings
- 04/04/22
- Flotek regains compliance with NYSE continued listing standard
- 02/17/22
- Flotek nearly doubles on reopening after announcing $1B-plus contract award
- 02/17/22
- Flotek trading resumes
- 03/30/22
- Flotek options imply 13.2% move in share price post-earnings
- 03/28/22
- Flotek options imply 12.3% move in share price post-earnings
- 03/21/22
- Flotek options imply 15.7% move in share price post-earnings
- 03/17/22
- Flotek options imply 15.2% move in share price post-earnings
|
